SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
___________________
Date of Report (Date of earliest event reported) May 22, 2001
BICO, INC.
(Exact name of registrant as specified in its charter)
Pennsylvania 0-10822 25-1229323
(State of other jurisdiction (Commission File Number) (IRS Employer
of incorporation) Identification No.)
2275 Swallow Hill Road, Bldg. 2500, Pittsburgh, Pennsylvania 15220
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (412) 429-0673
_________________________________________________________
(Former name or former address,if changes since last report)
Item 1. Change in Control of Registrant.
Not applicable.
Item 2. Acquisition or Disposition of Assets.
Not applicable.
Item 3. Bankruptcy or Receivership.
Not applicable.
Item 4. Changes in Registrant's Certifying Accountant
Not applicable.
Item 5. Other Events.
Biocontrol Technology, Inc., a division of BICO,
Inc., announced today it will display its
technology and exhibit its production facility at two
upcoming trade shows, the Showcase for Commerce
and the Medical Design & Manufacturing East 2001
show.
Item 6. Resignation of Registrant's Directors.
Not Applicable
Item 7. Financial Statement, Pro Forma Financial
Information and Exhibits.
(a) Financial Statements and Businesses Acquired
- Not Applicable.
(b) Pro Forma Financial Information
- Not Applicable.
(c) Exhibits - Press Release.
SIGNATURES
Pursuant to the requirement of the Securities Exchange
Act of 1934, the Registrant has duly caused this Report to
be signed on its behalf by the undersigned hereunto duly
authorized.
BICO, INC.
by /s/ Fred E. Cooper
Fred E. Cooper, CEO
DATED: May 22, 2001
BICO DIVISION, BIOCONTROL TECHNOLOGY, TO HIGHLIGHT
OPERATIONS AT UPCOMING TRADE SHOWS
Indiana, PA May 22, 2001 - Biocontrol Technology,
Inc., a division of BICO, Inc. (OTCBB: BIKO), announced
today it will display its technology and exhibit its
production facility at two upcoming trade shows, the
Showcase for Commerce and the Medical Design &
Manufacturing East 2001 show.
The Showcase for Commerce is scheduled for May 31 and
June 1, 2001 at the Cambria County War Memorial Arena in
Johnstown, PA. The Medical Design & Manufacturing East 2001
exposition will be held June 5-7, 2001 at the Jacob K.
Javits Convention Center in New York City.
Biocontrol Technology will display its product line
that includes the ThermoChem HT 1000 System built for BICO,
Inc. subsidiary ViaCirq, Inc., the Diasensor 2000
noninvasive glucose monitor built for Diasense, Inc., the
theraPORT vascular access device, and the Functional
Electrical Stimulator for The Cleveland FES Center at Case
Western Reserve University to restore lost muscle movement
due to paralysis.
"These two upcoming trade shows will further progress
the development of Biocontrol Technology's product line and
our focus on contract manufacturing," said David McMurry,
president of Biocontrol Technology. "The shows provide us
with the opportunity to highlight our products and give us
the ability to foster relationships with potential
customers."
The Showcase for Commerce is the region's largest
business and industry show. The event brings together
regional and national companies to develop new contacts and
improve markets for goods and services. The exhibits are
open to the public on June 1 from 10:00 a.m. to 6:00 p.m.
The 19th annual MD&M East Conference & Exposition is
the world's biggest show for medical manufacturers. The
show features exhibits from 800 companies who supply
materials, equipment, components, and services used in the
design and manufacture of medical products and devices.
Biocontrol Technology has operations in Indiana, Pa
and serves as the research, development and manufacturing
division of BICO. Located in Pittsburgh, Pa, BICO is
involved in the development and manufacture of biomedical
devices and environmental products.
FOR FURTHER INFORMATION, CONTACT:
Investors Media
Diane McQuaide Susan Taylor
1.412.429.0673 phone 1.412.429.0673 phone
1.412.279.9690 fax 1.412.279.5041 fax
INVESTOR RELATIONS NEWSLINE NUMBER: 1.800.357.6204
www.bico.com www.biocontrol-tech.com